Hookipa Biotech AG Sustainability Profile
Hookipa Biotech AG, headquartered in Austria, is a pioneering company in the biotechnology sector, specialising in innovative immunotherapies for cancer treatment. Founded in 2011, Hookipa has made significant strides in the development of its proprietary platform, which harnesses the power of viral vectors to stimulate robust immune responses against tumours. With a focus on advancing its lead product candidates, Hookipa's unique approach combines cutting-edge science with a commitment to improving patient outcomes. The company has established a strong market position, recognised for its groundbreaking research and development efforts in the field of oncolytic immunotherapy. As it continues to expand its operational reach, Hookipa Biotech AG remains dedicated to transforming cancer care through its novel therapeutic solutions.
DitchCarbon Score
How does Hookipa Biotech AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hookipa Biotech AG's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hookipa Biotech AG's reported carbon emissions
Hookipa Biotech AG, headquartered in Austria (AT), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, any potential climate initiatives or emissions data may be cascaded from its parent organization. However, no specific sources or initiatives have been identified in this context. Without concrete emissions data or reduction commitments, it is challenging to assess Hookipa Biotech AG's climate impact or sustainability efforts within the biotechnology sector.
How Carbon Intensive is Hookipa Biotech AG's Industry?
How Carbon Intensive is Hookipa Biotech AG's Location?
Hookipa Biotech AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hookipa Biotech AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
